Surrey Heartlands

Joint Formulary & PAD

Aripiprazole - Behavioural and Psychological Symptoms of Dementia

You are here : Home > Formulary Search > Aripiprazole - Behavioural and Psychological Symptoms of Dementia

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Oral solution
  • Oro-dispersible tablets
  • Tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
Guidelines
Off Label
SPC
Restrictions / Comments :
Important

Initiation by a mental health specialist and stabilisation for at least 3 months before any request to transfer prescribing responsibility.

Documentation

Guidelines (Local)
Guidelines - Managing Non-Cognitive Symptoms in People Living With Dementia - February 2023.pdf
Webpage
NICE NG97 - Dementia -assessment, management and support for patients and carers - June 2018

PAD Profile

ChemicalSubstance :
Aripiprazole
Indication :
Behavioural and Psychological Symptoms of Dementia
Group Name :
Keywords :
BPSD, dementia, aggression, Non-cognitive symptoms of dementia Alzheimer's Disease, aggression, antipsychotics, anticholinergic burden
Brand Names Include :
Zyprexa
Important Information :

Initiation by a mental health specialist and stabilisation for at least 3 months before any request to transfer prescribing responsibility.

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Behavioural and Psychological Symptoms of Dementia
Supporting Documents :
2

Other Indications

Below are listed other indications that Aripiprazole is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Behavioural and Psychological Symptoms of Dementia.

Committee Recommendations (2)

01 Feb 23 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Integrated Care System Area Prescribing Committee agreed the updated resource pack for use by primary care prescribers for managing non-cognitive symptoms in people living with dementia.

03 May 17 - Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
GENERIC Olanzapine has been considered by the PCN and has been assigned a BLUE traffic light status

NOTE - the branded product, Zyprexa, was considered BLACK at the PCN in May 2017.